Isolation and Characterization of a Novel Lytic Phage N22 and Its Effect on Drug-Resistant Klebsiella Pneumoniae
This study provides a preliminary investigation into the effects of combining CAZ/AVI with phage therapy, highlighting its potential significance in developing novel therapeutic strategies for bacterial infections resistant to CAZ/AVI. The findings underscore the importance of advancing highly effective phage agents as alternative treatment modalities for patients with infections refractory to conventional antibiotics.
Authors
- Kunhao Qin (ORCID: https://orcid.org/0000-0002-3740-4661)
- Chengying Hong
- Huaisheng Chen
- Wei Li (ORCID: https://orcid.org/0000-0002-6960-7404)
- Mengyao Li (ORCID: https://orcid.org/0000-0002-2684-7045)
- Xueyan Liu (ORCID: https://orcid.org/0000-0002-7229-2810)
- Wei Huang (ORCID: https://orcid.org/0000-0002-8569-5184)
- Dongyu Liu (ORCID: https://orcid.org/0000-0002-8915-2785)
- Puqiao Lian
Institutions
- Jinggangshan University (CN)
- Southern University of Science and Technology (CN)
- Shenzhen Second People's Hospital (CN)
Publication Details
- Journal
- Infection and Drug Resistance
- Published
- 2025-04-01
- DOI
- https://doi.org/10.2147/idr.s515363
- Citations
- 2
- Primary Topic
- Bacteriophages and microbial interactions
- Type
- article
- Field-Weighted Citation Impact
- 3.43
Funders
- National Natural Science Foundation of China
- National Key Research and Development Program of China